This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by de la Maza, L M Articles by Czarniecki, C W Search for Related Content PubMed PubMed Citation Articles by de la Maza, L M Articles by Czarniecki, C W

 Previous Article  |  Next Article 

Infect Immun. 1987 November; 55(11): 2727-2733

The antichlamydial, antiviral, and antiproliferative activities of human gamma interferon are dependent on the integrity of the C terminus of the interferon molecule.

Department of Pathology, University of California, Irvine 92717.

ABSTRACT

The effects of recombinant human gamma interferon (rHuIFN-gamma; two identical monomers of 140 residues in length) and of two re-engineered C-terminal variants, rHuIFN-gamma Tetra-Ser (residues 129 to 132 replaced by serine) and rHuIFN-gamma 125 (two identical monomers of 125 residues each with the last 14 residues plus an additional alanine from the C terminus deleted), were compared in terms of several in vitro biological activities. By using three different human cell lines (HeLa 229, HEp-2, and A549), the interferons were tested for their ability to inhibit: (i) growth of Chlamydia trachomatis; (ii) replication of encephalomyocarditis virus; and (iii) cell growth. rHuIFN-gamma restricted the growth of chlamydiae to 50% of the non-IFN-treated control at concentrations ranging from 0.01 to 0.05 ng/ml, depending on the cell type assayed. One of the modified proteins, rHuIFN-gamma Tetra-Ser, also decreased the growth of chlamydiae, but it required a concentration of approximately 0.5 ng/ml to produce 50% inhibition. rHuIFN-gamma 125 had the lowest antichlamydial activity of the three IFN-gamma variants tested; concentrations of 1 to 20 ng/ml were needed to reduce the growth of C. trachomatis to 50% of that of the control. The relative antiviral and antiproliferative activities of the three IFN-gamma preparations paralleled their antichlamydial activities in these three cell lines. The antiencephalomyocarditis virus activities of rHuIFN-gamma Tetra-Ser and rHuIFN-gamma 125 were reduced by approximately 10-fold and 10(2)- to 10(3)-fold, respectively, compared with the antiviral activity of rHuIFN-gamma. Proliferation of the three cell lines was restricted to approximately 50% of the control with 0.5 to 10 ng of rHuIFN-gamma per ml. Inhibition of cell growth by rHuIFN-gamma Tetra-Ser was significant only at concentrations equal to or greater than 30 ng/ml, and the rHuIFN-gamma 125 variant did not significantly decrease the growth of any of the three cell lines at the concentrations tested. These results suggest that the C-terminal portion of rHuIFN-gamma is critical for maintaining the conformation necessary for inducing the antichlamydial, antiviral, and antiproliferative activities of the molecule.

This article has been cited by other articles:

• Slepenkin, A., Enquist, P.-A., Hagglund, U., de la Maza, L. M., Elofsson, M., Peterson, E. M. (2007). Reversal of the Antichlamydial Activity of Putative Type III Secretion Inhibitors by Iron. Infect. Immun. 75: 3478-3489 [Abstract] [Full Text]  
• Mironova, R., Niwa, T., Dimitrova, R., Boyanova, M., Ivanov, I. (2003). Glycation and Post-translational Processing of Human Interferon-{gamma} Expressed in Escherichia coli. J. Biol. Chem. 278: 51068-51074 [Abstract] [Full Text]  
• Camejo, E. H., Rosengren, B., Camejo, G., Sartipy, P., Fager, G., Bondjers, G. (1995). Interferon Gamma Binds to Extracellular Matrix Chondroitin-Sulfate Proteoglycans, Thus Enhancing Its Cellular Response. Arterioscler. Thromb. Vasc. Bio. 15: 1456-1465 [Abstract] [Full Text]  
• Feng, G., Gray, P., Shepard, H., Taylor, M. (1988). Antiproliferative activity of a hybrid protein between interferon-gamma and tumor necrosis factor-beta. Science 241: 1501-1503 [Abstract]